Inhibition of energy metabolism in cerebral cortex of young rats by the medium-chain fatty acids accumulating in MCAD deficiency

Brain Research

Volumn 1030, Issue 1, 2004, Pages 141-151

  Reis De Assis, Dênis ^a   Maria, Rita De Cássia ^a   Borba Rosa, Rafael ^a   Schuck, Patrícia Fernanda ^a   Ribeiro, César Augusto João ^a   Da Costa Ferreira, Gustavo ^a   Dutra Filho, Carlos Severo ^a   Terezinha De Souza Wyse, Angela ^a   Duval Wannmacher, Clóvis Milton ^a   Santos Perry, Marcos Luiz ^a   Wajner, Moacir ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Servico Genet Medica Do Hosp C   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

cis 4 decenoic acid; Decanoic acid; Energy metabolism; Medium chain acyl coenzyme A dehydrogenase deficiency; Octanoic acid

Indexed keywords

4 DECANOIC ACID; ACETIC ACID DERIVATIVE; CARBON DIOXIDE; CITRATE SYNTHASE; CITRIC ACID; CREATINE KINASE; CYTOCHROME C OXIDASE; DECANOIC ACID DERIVATIVE; GLUCOSE DERIVATIVE; MEDIUM CHAIN FATTY ACID; OCTANOIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; CONTROLLED STUDY; CYTOSOL; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ESSENTIAL FATTY ACID DEFICIENCY; EVALUATION; METABOLITE; MITOCHONDRION; NEUROLOGIC DISEASE; NONHUMAN; PARAMETER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ACETATES; ACYL-COA DEHYDROGENASE; AGE FACTORS; ANIMALS; ANTIFUNGAL AGENTS; ANTIHYPERTENSIVE AGENTS; CARBON RADIOISOTOPES; CEREBRAL CORTEX; CITRATE (SI)-SYNTHASE; CREATINE KINASE; DECANOIC ACIDS; ELECTRON TRANSPORT; ENERGY METABOLISM; FATTY ACIDS; LIPID METABOLISM, INBORN ERRORS; OCTANOIC ACIDS; RATS; RATS, WISTAR;

EID: 9544240340     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.10.010     Document Type: Article

References (66)

1. M.A. Arstall, C. Bailey, W.L. Gross, M. Bak, J.L. Balligand, and R.A. Kelly Reversible S-nitrosation of creatine kinase by nitric oxide in adult rat ventricular myocytes J. Mol. Cell. Cardiol. 30 1998 979 988
2. B.J. Bergen, D.A. Stumpf, R. Haas, J.K. Parks, and L.A. Eguren A mechanism of toxicity of isovaleric acid in rat liver mitochondria Biochem. Med. 27 1982 154 160
3. M.N. Berry, D.G. Clark, A.R. Grivell, and P.G. Wallace The calorigenic nature of hepatic ketogenisis: an explanation for the stimulation of respiration induced by fatty acids substrates Eur. J. Biochem. 131 1983 205 214
4. S.O. Burmistrov, O.P. Mashek, and A.M. Kotin The action of acute alcoholic intoxication on antioxidant system and creatine kinase activity in the brain of rat embryos Eksp. Klin. Farmakol. 55 1992 54 56
5. D.S. Cassarino, and J.P. Bennett Jr. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration Brain Res. Rev. 29 1999 1 25
6. P.M. Coates New developments in the diagnoses and investigation of mitochondrial fatty acid oxidation disorders Eur. J. Pediatr. 1994 S49 S56
7. G. Cohen, and N. Kesler Monoamine oxidase and mitochondrial respiration J. Neurochem. 73 1999 2310 2315
8. A.M. Das, R. Fingerhut, R.J.A. Wanders, and K. Ullrich Secondary respiratory chain defect in a boy with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: possible diagnostic pitfalls Eur. J. Pediatr. 159 2000 243 246
9. 2+-dependent ATPase activity in human red cell membranes Biochem. J. 248 1987 511 516
10. +-ATPase activity induced by octanoic acid in rat cerebral cortex in vitro Neurochem. Res. 28 2003 1255 1263
11. S. Di Donato Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration J. Inherit. Metab. Dis. 23 2000 247 263
12. F. Feillet, G.G. Steinmann, C. Vianey-Saban, C. de Challou, N. Sadoul, E. Lefebvre, M. Vidailhet, and P.E. Bollaert Adult presentation of MCAD deficiency revealed by coma and severe arrhythmias Intensive Care Med. 29 2003 1594 1597
13. J.C. Fisher, W. Ruitenbeek, J.Á. Berden, J.M. Trijbels, J.H. Veerkamp, M. Stadhouders, R.C. Sengers, and A.J. Janssen Differential investigation of the capacity of succinate oxidation in human skeletal muscle Clin. Chim. Acta 153 1985 23 36
14. R. Haas, D.A. Stumpf, J.K. Parks, and L.A. Eguren Inhibitory effects of sodium valproate on oxidative phosphorylation Neurology 31 1981 1473 1476
15. J.P. Harpey, D. Heron, M. Prudent, C. Charpentier, P. Rustin, G. Ponsot, and V. Cormier Daire Diffuse leukodystrophy in an infant with cytochrome-c oxidase deficiency J. Inherit. Metab. Dis. 21 1998 748 752
16. G.F. Hoffmann, W. Meier-Augustein, S. Stockler, R. Surtess, D. Rartig, and W.L. Nyhan Physiology and pathology of organic acids in cerebral spinal fluid J. Inherit. Metab. Dis. 16 1993 648 669
17. B.P. Hughes A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera Clin. Chim. Acta 7 1962 597 604
18. E.C.A. Kaal, A.S. Vlug, M.W.J. Versleijen, M. Kuilman, E.A.J. Joosten, and P.R.D. Bär Chronic mitochondrial inhibition induces selective motoneuron death in vitro J. Neurochem. 74 2000 1158 1165
19. C.S. Kim, L.A. O'tuama, J.D. Mann, and C.R. Roe Effect of increasing carbon chain length on organic acid transport by the choroid plexus: a potential factor in Reye's syndrome Brain Res. 259 1983 340 343
20. C.S. Kim, C.R. Roe, and W.W. Ambrose l-Carnitine prevents mitochondrial damage induced by octanoic acid in the rat choroid plexus Brain Res. 536 1990 335 338
21. E.A. Konorev, N. Hogg, and B. Kalyanaraman Rapid and irreversible inhibition of creatine kinase by peroxinitrite FEBS Lett. 427 1998 171 174
22. M.A. Lea, and G. Weber Role of enzymes in homeostasis: VIII. Inhibition of the activity of glycolytic enzymes by free fatty acids J. Biol. Chem. 243 1968 1096 1102
23. W.T. Lee, P.J. Wang, C. Young, T.R. Wang, and Y.Z. Shen Cytochrome c oxidase deficiency in fibroblasts of a patient with mitochondrial encephalomyopathy J. Formos. Med. Assoc. 95 1996 709 711
24. G. Leipnitz, P.F. Schuck, C.A.J. Ribeiro, K.B. Dalcin, D.R. de Assis, A.G. Barschak, V. Pulrolnik, C.M.D. Wannmacher, A.T.S. Wyse, and M. Wajner Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro Neurochem. Res. 28 2003 771 777
25. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
26. D.W. McCandless Octanoic acid-induced coma and reticular formation energy metabolism Brain Res. 335 1985 131 137
27. C. Morin, J. Dub, B.H. Robinson, J. Lacroix, J. Michaud, M. De Braekeleer, G. Geoffroy, A. Lortie, C. Blanchette, M.A. Lambert, and G.A. Mitchell Stroke-like episodes in autosomal recessive cytochrome oxidase deficiency Ann. Neurol. 45 1999 389 392
28. W.H. Oldendorf Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids Am. J. Physiol. 224 1973 1450 1453
29. J.E. Olson, D. Holtzman, R. Sankar, C. Lawson, and R. Rosenberg Octanoic acid inhibits astrocyte volume control: implications for cerebral edema in Reye's syndrome J. Neurochem. 52 1989 1197 1202
30. W. Onkenhout, V. Venizelos, P.F.H. Van der Poel, M.P.M. Van der Heuvel, and B.J.H.M. Poorthuis Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders Clin. Chem. 41 1995 1467 1474
31. S.V. Pande, and M.C. Blanchaer Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl Coenzyme A esters J. Biol. Chem. 246 1971 402 411
32. S.V. Pande, and J.F. Mead Inhibition of enzyme activities by free fatty acids J. Biol. Chem. 243 1968 6180 6185
33. W.D. Parker, R. Haas, D.A. Stumpf, and L.A. Eguren Effects of octanoate on rat brain and liver mitochondria Neurology 33 1983 1374 1377
34. W.M. Partridge, J.D. Connor, and I.L. Crawford Permeability changes in the blood-brain barrier: causes and consequences CRC Crit. Rev. Toxicol. 3 1975 159 199
35. O. Ramirez, and E. Jiménez Opposite transitions of chick brain catalytically active cytosolic creatine kinase isoenzymes during development Int. J. Dev. Neurosci. 18 2000 815 823
36. P. Rinaldo, K. Raymond, A. Al-Odaib, and M. Bennett Clinical and biochemical features of fatty acid oxidation disorders Curr. Opin. Pediatr. 10 1998 615 621
37. C.R. Roe, and J. Ding Mitochondrial fatty acids disorders C.R. Scriver A.L. Beaudet W.L. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease 8th edition 2001 McGraw-Hill New York 1909 1963
38. W. Ruintenbeek, P.J.E. Poels, D.M. Turnbull, B. Garavaglia, R.A. Chalmers, R.W. Taylor, and F.J.M. Gabreëls Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency J. Neurol. Neurosurg. Psychiatry 58 1995 209 214
39. P. Rustin, D. Chretien, T. Bourgeron, B. Gérard, A. Rötig, J.M. Saudubray, and A. Munnich Biochemical and molecular investigations in respiratory chain deficiencies Clin. Chim. Acta 228 1994 35 51
40. M.K. Salo, J. Rapola, H. Somer, H. Pihko, M. Koivileko, and H. Tritschler Oxidase deficiency Arch. Dis. Child. 67 1992 1033 1035
41. F.E. Samson, N. Dahl, and D.R. Dahl A study on narcotic action of the short chain fatty acids J. Biol. Chem. 1956 1291 1298
42. R. Santer, E. Schmidt-Sommerfeld, Y.K. Leung, J.E. Fischer, and E. Lebenthal Medium-chain acyl-CoA dehydrogenase deficiency: electron microscopic differentiation from Reye syndrome Eur. J. Pediatr. 150 1990 111 114
43. A.H. Schapira, V.M. Mann, J.M. Cooper, D. Dexter, S.E. Daniel, P. Jenner, J.B. Clark, and C.D. Marsden Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease J. Neurochem. 55 1990 2142 2145
44. R. Scholz, M.S. Olson, A.J. Schwabe, U. Schwabe, C. Noell, and W. Braun The effect of fatty acids on the regulation of pyruvate dehydrogenase in perfused liver Eur. J. Biochem. 86 1978 519 530
45. 2 production following addition of octanoate and oleate in perfused rat liver Eur. J. Biochem. 141 1984 223 230
46. J.B. Schulz, R.T. Matthews, T. Klockgether, J. Dichgams, and M.F. Beal The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative disease Mol. Cell. Biochem. 174 1997 193 197
47. A.M. Sgaravatti, R.B. Rosa, P.F. Schuck, C.A. Ribeiro, C.M. Wannmacher, A.T. Wyse, C.S. Dutra-Filho, and M. Wajner Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease Biochim. Biophys. Acta 1639 2003 232 238
48. J.M. Shoffner Oxidative phosphorylation defects and Alzheimer's disease Neurogenetics 1 1997 193 197
49. O. Stachowiak, M. Dolder, T. Wallimann, and C. Richter Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation J. Biol. Chem. 273 1998 16694 16699
50. D.A. Stumpf, J. McAfee, J.K. Parks, and L.A. Eguren Propionate inhibition of succinate:CoA ligase (GDP) and the citric acid cycle in mitochondria Pediatr. Res. 14 1980 1127 1131
51. +-ATPase leading to inhibition and inactivation Biochim. Biophys. Acta 1024 1990 32 40
52. + ATPase activity following octanoate administration Pediatr. Res. 14 1980 844 845
53. D.A. Trauner Pathologic changes in a rabbit model of Reye's syndrome Pediatr. Res. 16 1982 950 953
54. D.A. Trauner, and H. Adams Intracranial pressure elevations during octanoate infusion in rabbits: an experimental model of Reye's syndrome Pediatr. Res. 15 1981 1097 1099
55. M.H. Tulinius, E. Holme, B. Kristiansson, N.G. Larsson, and A. Oldfors Mitochondrial encephalomyopathies in childhood: I. Biochemical and morphologic investigations J. Pediatr. 119 1991 242 250
56. M. Tulinius, H. Holme, B. Kristiansson, N.G. Larsson, and A. Oldfors Mitochondrial encephalomyopathies in childhood: II. Clinical manifestations and syndromes J. Pediatr. 119 1991 251 259
57. T. Tyni, A. Majander, H. Kalimo, J. Rapola, and H. Pihko Pathology of skeletal muscle and impaired respiratory chain function in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency with the G 1528 C mutation Neuromuscul. Dis. 6 1996 327 337
58. F.V. Ventura, J.P.N. Ruiter, L. Ijlst, I.T. Almeida, and R.J.A. Wanders Inhibition of oxidative phosphorylation by palmitoyl-CoA in digitonin permeabilized fibroblasts: implications for long-chain fatty acid β-oxidation disorders Biochim. Biophys. Acta 1272 1995 14 20
59. F.V. Ventura, J.P.N. Ruiter, L. Ijlst, I. Tavares de Almeida, and R.J.A. Wanders Inhibitory effect of 3-hydroxyacyl-CoAs and other long-chain fatty acid β-oxidation intermediates on mitochondrial oxidative phosphorylation J. Inherit. Metab. Dis. 19 1996 161 164
60. T. Wallimann, M. Dolder, U. Schlattner, M. Eder, T. Hornemann, E. O'Gorman, A. Ruck, and D. Brdiczka Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology BioFactors 8 1998 229 234
61. G. Weber, M.A. Lea, H.J. Convery, and N.B. Stamm Regulation of gluconeogenesis and glycolysis: studies of mechanisms controlling enzyme activity Adv. Enzyme Regul. 6 1968 101 123
62. T.A. Willis, J. Davidson, R. George, F. Gray, K. Poulton, P. Ramani, and W. Whitehouse Cytochrome oxidase deficiency presenting as birth asphyxia Dev. Med. Child Neurol. 42 2000 414 417
63. H. Wolosker, R. Panizzutti, and S. Englender Inhibition of creatine kinase by S-nitrosoglutathione FEBS Lett. 392 1996 274 276
64. J.M. Wood, E.T. Wallick, A. Schwartz, and C. Chang The effect of palmitoyl-coenzyme A on rat heart and liver mitochondria. Oxygen consumption and palmitoylcarnitine formation Biochim. Biophys. Acta 486 1977 331 340
65. H. Wörle, B. Köhler, W. Schlote, P. Winkler, and C.K. Bastanier Progressive cerebral degeneration of childhood with liver disease (Alpers Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation Clin. Neuropathol. 17 1998 63 68
66. M. Zerviani, B. Bertagnolia, and G. Uziel Neurological presentation of mitochondrial diseases J. Inherit. Metab. Dis. 19 1996 504 520